$200m saved as Phar­mac

The New Zealand Herald - - News - Lucy Ben­nett

Peo­ple who need ex­pen­sive Phar­mac-funded drugs can ac­cess them re­gard­less of their DHB’s abil­ity to pay for it, un­der changes to the drug-fund­ing model.

From July 1, Phar­mac will take over re­spon­si­bil­ity from District Health Boards (DHBs) for buy­ing all their medicines, sav­ing close to $200 mil­lion over four years through its pur­chas­ing power.

Un­til now, Phar­mac man­aged the DHBs’ com­mu­nity drug-buy­ing bud­get while DHBs held their own bud­get for buy­ing medicines for their hos­pi­tals.

Un­der the new ar­range­ment, DHBs will turn over that bud­get to Phar­mac as well, to take ad­van­tage of the agency’s pur­chas­ing power.

“This means, that no mat­ter where pa­tients are in New Zealand,

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.